SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-24-003926
Filing Date
2024-06-03
Accepted
2024-06-03 16:01:21
Documents
13
Period of Report
2024-05-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 29696
  Complete submission text file 0001829126-24-003926.txt   202584

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE opgn-20240529.xsd EX-101.SCH 2991
3 XBRL LABEL FILE opgn-20240529_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE opgn-20240529_pre.xml EX-101.PRE 22343
16 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3645
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 241013494
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)